Home Johnson & Johnson Earnings May Be Scrutinized For Deal Buzz, Product Snags
 

Keywords :   


Johnson & Johnson Earnings May Be Scrutinized For Deal Buzz, Product Snags

2016-01-25 23:04:06| Biotech - Topix.net

On average, analysts reporting to Thomson Reuters are looking for JNJ earnings of $1.42 a share on top-line sales of $17.9 billion. Short-term option traders are looking for the earnings news to potentially generate a 2.5% move on the stock in either direction.

Tags: product deal johnson earnings

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
More »